Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

The pharmaceutical industry is pushing back against Governor Cuomo's prescription drug price control proposal, arguing that it would lead to cuts in research. And they are pointing the finger at insurance companies and companies known as pharmacy benefit managers for the high costs paid by patients. Peter Pitts is a former FDA Associate Commissioner for External Relations and is now President of the Center for Medicine in the Public Interest.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Government must avoid change in Medicare Part D

Government must avoid change in Medicare Part D

...  Read more

The Wrong Way to Dispose of Drugs

The Wrong Way to Dispose of Drugs

...  Read more

Regenerative Medicine Can Help Make America Great

Regenerative Medicine Can Help Make America Great

The problem isn’t over-regulation. It’s outdated regulation....  Read more

DRUGWONKS BLOG